Program Goals

The purpose of this activity is to educate participants on the Ibis Technology and discuss the new research on Influenza surveillance assays.  Details on the influenza virus will encompass how the virus evolves to create a pandemic.  The discussion will highlight the ability of the new Influenza surveillance assay to track the viral evolution over time.

Target Audience

Laboratory Professionals (directors and medical laboratory scientists/technicians) working in the areas of Molecular Diagnostics, Clinical Microbiology or Clinical Virology in hospital institutions, reference laboratories,  and public health departments.

 

Educational Objectives

Upon completion of this activity, participants should be able to:
1. Identify the key elements that comprise the Ibis Technology.
2. Describe the influenza virus structure and how it evolves over time.
3. Discuss the application of the Ibis Technology as a surveillance tool for tracking the emergence of new influenza virus strains.

Faculty

David J. Ecker, Ph.D.   
Chief Scientific Officer          
Ibis Biosciences, Inc.
Subsidiary of Abbott Molecular Inc.
Carlsbad, CA

Charlotte A. Gaydos, MS, MPH. DrPH 
Professor of Medicine
Johns Hopkins University
Division of Infectious Diseases
International STD and Biothreat Research Laboratory
Baltimore, MD

Credit Designation - Lab Professional, P.A.C.E.^®

The American Society for Clinical Laboratory Science's Professional Acknowledgment for Continuing Education (P.A.C.E.^®) Program will provide 1.0 contact hour of credit.

Commercial Support Statement

This activity is supported by an educational grant from Abbott Molecular.

Disclosure of Conflicts of Interests

Dane Garvin Ltd. (DGL) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity.

Faculty Disclosure

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this P.A.C.E. accredited activity:

Name	Type	Commercial Supporter
David J. Ecker, PhD	Employee	Abbott Molecular
Charlott A. Gaydos, MS, MPH, DrPH	Grant / Research Support	Abbott

Dane Garvin Ltd. Disclosure

Employees of Dane Garvin Ltd. (DGL), a joint sponsor for this activity, do not have any financial relationships or relationships to products or devices with any commercial interests related to the content of this educational activity for any amount during the past 12 months. DGL further discloses that a spouse is employed in an administrative capacity with the educational grantor and is not in a position to affect or have input into the content of this educational activity.

How to Obtain P.A.C.E.^® Credit

Viewers are expected to complete the presentation before attempting to submit contact information and the session evaluation. Successful completion will lead to the issuance of a certificate for 1.0 contact hour of P.A.C.E.^® approved continuing education. To receive credit, the course must be completed between September 29, 2009 - September 29, 2010.

Participation in this activity should be completed in approximately 1 hours. Please follow these steps in order to receive P.A.C.E.^® credit for viewing the webcast: 

• Read all of the information above.
• View the complete webcast program.
• Click on the "Lab Professional" link to apply for P.A.C.E.^® credit.
• Complete the online registration (registration is free).
• Complete the online test and/or evaluation. Participants must receive a test score of at least 75% and answer all evaluation questions to receive P.A.C.E.^® credit.
  
• After successful completion of this process, you will be redirected to the ASCLS CE Organizer where you may create and print an official ASCLS P.A.C.E.^® certificate based on your attendance and completion of this ASCLS-sponsored P.A.C.E.^® approved learning activity.